SOCS2 and neoplasm: SOCS2-AS1 exerted its tumor-suppressive activity through interaction with and promotion of AURKA ubiquitin degradation, thereby reducing the levels of AURKA protein and its target mRNAs—including those mRNAs directly associated with cancer cell growth.